Sex differences in effectiveness of first-line tumor necrosis factor inhibitors in axial spondyloarthritis; results from fifteen countries in the EuroSpA research collaboration network

Pasoon Hellamand, Marleen G H Van de Sande, Lykke Midtbøll Ørnbjerg, Thomas Klausch, Michael Nurmohamed, R Van Vollenhoven, D.C. Nordström, Anna-Mari Hokkanen, MJ Santos, Elsa Vieira-Sousa, A. G. Loft, Bente Glintborg, Mikkel Østergaard, U Lindström, Johan Karlsson Wallman, Brigitte Michelsen, Adrian Ciurea, M. J. Nissen, Catalin Codreanu, C MoogosanG. Macfarlane, G. T. Jones, Karin Laas, Z Roter, M Tomsic, I Castrejon, M Pombo-Suarez, B Gudbjörnsson, A. J. Geirsson, E. Kristianslund, J. Vencovsky, Lucie Nekvindova, S Gulle, B Zengin, Merete Lund Hetland, I Van der Horst- Bruinsma

Abstract

Sex differences in effectiveness of first-line tumor necrosis factor inhibitors in axial spondyloarthritis; results from fifteen countries in the EuroSpA research collaboration network
Original languageEnglish
Publication date2022
Publication statusPublished - 2022
EventEULAR 2022 - Copenhagen
Duration: 1 Jun 20224 Jun 2022

Conference

ConferenceEULAR 2022
CityCopenhagen
Period01/06/202204/06/2022

Cite this